Gut immune cells—A novel therapeutical target for cardiovascular disease?

Despite scientific and clinical advances during the last 50 years cardiovascular disease continues to be the main cause of death worldwide. Especially patients with diabetes display a massive increased cardiovascular risk compared to patients without diabetes. Over the last two decades we have learn...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganesh, Naresh, van der Vorst, Emiel P. C., Spiesshöfer, Jens, He, Shun, Burgmaier, Mathias, Findeisen, Hannes, Lehrke, Michael, Swirski, Filip K., Marx, Nikolaus, Kahles, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421162/
https://www.ncbi.nlm.nih.gov/pubmed/36046186
http://dx.doi.org/10.3389/fcvm.2022.943214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421162/
https://www.ncbi.nlm.nih.gov/pubmed/36046186
http://dx.doi.org/10.3389/fcvm.2022.943214

Ejemplares similares